ADRIANA O'NEAL: Open Payments
NPI 1558579664 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 9 payments from 7 companies in 2025. Trend: 2023 $33 · 2024 $1,115 · 2025 $824
Food & beverage: $824
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $247 |
| Supernus Pharmaceuticals, Inc. | 1 | $133 |
| Neurocrine BioSciences, Inc. | 1 | $128 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $122 |
| Exact Sciences Corporation | 2 | $50 |
| MOTIVA USA, LLC | 1 | $22 |
Products named: REXULTI, Qelbree, INGREZZA, COBENFY, CAPLYTA, Cologuard Collection Kit, Motiva Implant Matrix.
Industry payments across TX — which companies pay providers there.
